SCHEMBL9532773

SCHEMBL9532773

c1ccc(CON=C(c2ccccn2)c2ccccn2)cc1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 8/20 0.57
NPC1 O15118 7/20 0.57
RAB9A P51151 7/20 0.57
LMNA P02545 3/20 0.57
L3MBTL1 Q9Y468 2/20 0.57
KLF5 Q13887 1/20 0.52
KMT2A Q03164 2/20 0.47
PKM P14618 4/20 0.44
MITF O75030 1/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
NAPRT Q6XQN6 1/20 0.43
P4HTM Q9NXG6 1/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
AGTR1 P30556 1/20 0.41
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796749 0.92 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL8289135 0.92 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL1796753 0.92 NPC1 (0.53) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL17257187 0.84 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL9532057 0.83 NPC1 (0.54) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL9530015 0.83 KDM4E (0.57) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL9529568 0.78 KDM4E (0.51) NPC1RAB9AKMT2APKMMITF
SCHEMBL9528646 0.76 CES2 (0.50) NPC1RAB9ALMNAL3MBTL1KMT2A
SCHEMBL9532752 0.75 RAB9A (0.47) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1
SCHEMBL10452205 0.74 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9ALMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3143055-A2 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS CONTAINING A CYANO GROUP Bridgestone Corporation (JP) 2017-03-22 EP claimed
WO-2015175280-A2 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS CONTAINING A CYANO GROUP BRIDGESTONE CORPORATION (JP) 2015-11-19 WO claimed
JP-53116378-A None JP disclosed
EP-3143055-B1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS CONTAINING A CYANO GROUP BRIDGESTONE CORP (JP) 2019-09-04 EP disclosed
CN-100482646-C N- [ phenyl (piperidin-2-yl) methyl ] benzamide derivatives, their preparation and their use in therapy SANOFI AVENTIS (FR) 2009-04-29 CN disclosed
CN-1662497-A N- [ phenyl (piperidin-2-yl) methyl ] benzamide derivatives, their preparation and their use in therapy SANOFI AVENTIS (FR) 2005-08-31 CN disclosed
EP-0366006-B1 PYRIDYLKETOXIME ETHER COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING IT KAKEN PHARMACEUTICAL CO., LTD. (JP) 1993-09-29 EP disclosed
JP-S53116378-A PYRIDYLKETONEOXIMEBENZYLETHERS PROCESS FOR THEIR PREPARATION AND HERBICIDES CONTAINING THE SAME SUMITOMO CHEM CO LTD 1978-10-11 JP disclosed